Interpace Biosciences Inc (IDXG)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Jack E. Stover
Employees:
90
MORRIS CORPORATE CENTER 1,, BUILDING C, 300 INTERPACE PARKWAY, PARSIPPANY, NJ 07054
412-224-6100

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries.

Data derived from most recent annual or quarterly report
Market Cap 16.087 Million Shares Outstanding4.104 Million Avg 30-day Volume 341.698 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.35
Price to Revenue0.127 Debt to Equity-0.8173 EBITDA977 Thousand
Price to Book Value0.0 Operating Margin2.0898 Enterprise Value59.012 Million
Current Ratio0.957 EPS Growth0 Quick Ratio0.782
1 Yr BETA 0.6513 52-week High/Low 0.0 / Profit Margin-40.7952
Operating Cash Flow Growth67.425 Free Cash Flow to Firm (FCFF) TTM 17.148 Million Free Cash Flow to Equity (FCFE) TTM3.135 Million
Altman Z-Score-19.5942
View SEC Filings from IDXG instead.

View recent insider trading info

Interpace Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IDXG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IDXG

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-01 by MCCARTHY CHRISTOPHER
  • 3: filed on 2023-05-03 by MCCARTHY CHRISTOPHER
  • 4: filed on 2022-02-02 by AGGARWAL VIJAY
  • 3: filed on 2022-02-02 by AGGARWAL VIJAY
  • 4: filed on 2021-05-25 by BURNELL THOMAS W.
  • 4: filed on 2021-03-12 by FREEBURG THOMAS JOHN
  • 4: filed on 2021-03-01 by KAMIN PETER
  • 3: filed on 2021-03-01 by KAMIN PETER
  • 4: filed on 2021-02-02 by GORMAN ROBERT J.
  • 4: filed on 2020-12-02 by STOVER JACK E

    • Events (8k)

  • 8-K: filed on 2023-11-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MCCARTHY CHRISTOPHER CHIEF FINANCIAL OFFICER

    • Officer
    		 35,644 2023-07-31 2

    AGGARWAL VIJAY

    • Director
    		 0 2022-02-01 0

    BURNELL THOMAS W. PRESIDENT & CEO

    • Officer
    • Director
    		 235,855 2021-05-21 0

    FREEBURG THOMAS JOHN CHIEF FINANCIAL OFFICER

    • Officer
    		 102,000 2021-03-10 0

    KAMIN PETER

    • 10% Owner
    		 1,422,525 2021-02-26 0

    GORMAN ROBERT J.

    • Director
    		 18,759 2021-01-29 0

    STOVER JACK E

    • FORMER OFFICER AND DIRECTOR
    		 No longer subject to file 2020-12-01 0

    EARLY JAMES

    • FORMER CHIEF FINANCIAL OFFICER
    		 No longer subject to file 2020-07-29 0

    SULLIVAN STEPHEN J

    • Director
    		 0 2020-07-09 0

    KEEGAN JOSEPH D

    • Director
    		 0 2020-07-09 0

    ROCCA FORTUNATO R.

    • Director
    		 0 2020-07-09 0

    LAMPE-ONNERUD CHRISTINA

    • Director
    		 2,391 2020-02-01 0

    MARCET PABLO

    • Director
    		 9,391 2020-02-01 0

    KNECHTEL FRED S. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2020-01-29 0

    RICHARD GREGORY CHIEF COMMERCIAL OFFICER

    • Officer
    		 No longer subject to file 2020-01-22 0

    MCCARTHY LAURENCE

    • Director
    		 No longer subject to file 2020-01-15 0

    1315 CAPITAL II, L.P.

    • 10% Owner
    		 0 2020-01-15 0

    AMPERSAND 2018 LIMITED PARTNERSHIP

    • 10% Owner
    		 0 2020-01-15 0

    LEV ERIC B.

    • Director
    		 0 2020-01-15 0

    CHAN EDWARD

    • Director
    		 0 2020-01-15 0

    SCHNOLL-SUSSMAN FELICE

    • Director
    		 4,800 2018-03-07 0

    NASGOVITZ WILLIAM J

    HEARTLAND ADVISORS INC

    • NO LONGER SUBJECT TO SEC. 16NO LONGER SUBJECT TO SEC. 16
    		 No longer subject to file 2016-10-14 0

    KRISHNAMURTI NAT INTERIM CFO

    • Officer
    		 8,793 2016-03-01 0

    GLORIKIAN HARRY

    • Director
    		 127,696 2016-02-03 0

    MIAO GRAHAM G CFO

    • Officer
    		 354,724 2015-12-28 0

    MELILLO GERALD R JR PRESIDENT, SALES SERVICES

    • Officer
    		 267,121 2015-11-25 0

    RATNAM KAPILA

    • Director
    		 0 2015-10-30 0

    FEDERSPIEL JOHN

    • Director
    		 166,665 2015-06-03 0

    DREISMANN HEINER

    • Director
    		 66,263 2015-06-03 0

    BELLE GERALD P.

    • Director
    		 298,017 2015-06-03 0

    LURKER NANCY CEO

    • Officer
    • Director
    		 1,404,998 2015-03-05 0

    SMITH JEFFREY EDWARD VP OF CORPORATE DEVELOPMENT

    • Officer
    		 1,272,170 2014-11-07 0

    CLIMACO JOHN M

    • Director
    		 33,122 2014-06-04 0

    LUBATKIN VERONICA

    • Director
    		 98,206 2013-06-04 0

    SAITTA JO ANN SVP AND CIO, GM GROUP DCA

    • Officer
    		 109,844 2013-03-01 0

    RYAN FRANK J

    • Director
    		 80,850 2011-05-31 0

    MICALI RICHARD P SENIOR VP, SALES SERVICES

    • Officer
    		 55,735 2011-03-03 0

    KERR DAVID E SENIOR VP BUSINESS DEVELOPMENT

    • Officer
    		 39,769 2011-03-03 0

    DRAZNER HOWARD SVP,BUS. DEV MEDICAL EDUCATION

    • Officer
    		 53,249 2010-11-29 0

    LIKOFF ROBERT OWEN CO-CEO, GROUP DCA

    • Officer
    		 0 2010-11-03 0

    DAVIS JACK CO-CEO, GROUP DCA

    • Officer
    		 0 2010-11-03 0

    VECSI JAN MARTENS

    • Director
    		 87,839 2010-06-03 0

    PIETRUSKI JOHN M

    • Director
    		 42,688 2009-06-04 0

    CURTI JOSEPH I

    • Director
    		 38,688 2009-06-04 0

    TILLES PETER PRESIDENT, TVG

    • Officer
    		 11,966 2009-04-01 0

    FARRELL JAMES G. VP, CORPORATE CONTROLLER

    • Officer
    		 13,843 2008-11-18 0

    MARQUARD MICHAEL CEO

    • Officer
    		 354,686 2008-06-11 0

    MCCARTHY NANCY EVP, HUMAN RESOURCES

    • Officer
    		 35,871 2008-02-27 0

    CONNOLLY KEVIN EVP, MARKETING SERVICES

    • Officer
    		 51,893 2008-02-27 0

    JACOBSON BETH FORMER EXEC VP & GC

    • Officer
    		 10,000 2006-03-10 0

    BUDD STEVEN K PRESIDENT

    • Officer
    		 728,266 2006-02-15 0

    COTUGNO STEPHEN EXECUTIVE VICE-PRESIDENT

    • Officer
    		 366,038 2006-02-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 22:15:04 UTC -10.3249 10.3949 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 21:45:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 21:15:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 20:45:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 20:15:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 19:45:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 19:15:04 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 18:45:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 18:15:03 UTC -10.3255 10.3955 80000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 17:45:03 UTC -10.3255 10.3955 75000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 17:15:03 UTC -10.3255 10.3955 75000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 16:45:03 UTC -10.3249 10.3949 75000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 16:15:03 UTC -10.3249 10.3949 75000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 15:45:03 UTC -10.3249 10.3949 75000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 15:15:03 UTC -10.3249 10.3949 75000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 14:45:02 UTC -10.3249 10.3949 25000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 14:15:03 UTC -10.3249 10.3949 25000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 13:45:03 UTC -10.3249 10.3949 25000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 13:15:03 UTC -10.3249 10.3949 25000
    INTERPACE BIOSCIENCES INC IDXG 2021-10-15 12:45:03 UTC -10.3249 10.3949 25000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments